Smithfield Trust’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-880
Closed -$11K 1057
2018
Q1
$11K Buy
880
+50
+6% +$710 ﹤0.01% 712
2017
Q4
$12K Sell
830
-1,120
-57% -$15.6K ﹤0.01% 730
2017
Q3
$28K Buy
+1,950
New +$25.2K ﹤0.01% 612
2013
Q3
Sell
-350
Closed -$5K 775
2013
Q2
$5K Buy
+350
New +$4.69K ﹤0.01% 686

Other funds holding MDRX

Smithfield Trust's MDRX Position: Q2 2018 in Review

Smithfield Trust sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2018, closing a stake of 880 shares — an estimated $11K sold.

Smithfield Trust first reported a position in MDRX in Q2 2013 and held it in 4 quarters. The position peaked at $28K in Q3 2017. 253 funds tracked by Wall St. Rank hold MDRX as of Q2 2018.

  • Smithfield Trust reported no remaining Veradigm Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Smithfield Trust sold 880 Veradigm Inc. Common Stock shares in Q2 2018, an estimated $11K.
  • Smithfield Trust first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 4 quarters.
  • Smithfield Trust's Veradigm Inc. Common Stock position peaked at $28K in Q3 2017.
  • 253 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2018.

Based on Smithfield Trust's 13F filing for Q2 2018, filed 16 Jul 2018.